Even though it’s been decades since Steve Burns searched for an animated dog on the popular children’s TV show Blue’s Clues, his ever-wholesome career still presents challenges in his personal life.

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...

On the left is integrase in its “intasome” structure of four identical four-part complexes (pink) that connect to create one 16-part complex that locks around viral DNA (blue). On the right is ...

Uncover the real story behind Steve's departure from Blue's Clues and the surprising truths fans never knew. Police may have found a new serial killer As national debt accelerates to $38 trillion, ...

Dan Wilson pulls Bryce Miller from the game during the fifth inning against the Toronto Blue Jays in Game 5 of the American League Championship Series. Steph Chambers / Getty Images In a different ...

The nightcap of Wednesday’s TNT doubleheader brings us a Central Division showdown as the St. Louis Blues welcome the Chicago Blackhawks. Chicago has shown real signs of progress early this season, ...

This amazing astronaut photo shows the bizarre whale-like shape of a Belizean tropical island. The coral-reef-covered structure is home to the Great Blue Hole, one of the deepest marine sinkholes on ...

'We understand our identity,' says St. Louis Blues coach Jim Montgomery as camp wraps up; he spoke after the game on Saturday, Oct. 4, 2025. Video provided by the team The Blues assigned five players ...

MANILA, Philippines & DALLAS--(BUSINESS WIRE)--A vast product portfolio with regional specialization and constant disruptions can complicate lifecycle management, collaboration and supply chain ...

Looking for a hint for today’s Connections puzzle? Below, we have clues to help you unlock whichever category has you stumped for the puzzle on September 22, 2025. Connections first launched on the ...

VectorY Therapeutics has seen the shape of things to come—and it involves finding fresh ways to deliver its gene therapies into the brain. The Dutch biotech has secured an exclusive option to evaluate ...